Developing Effective Alzheimer’s Disease Therapies: Clinical Experience and Future Directions

Alzheimer’s disease (AD) clinical trials, focused on disease modifying drugs and conducted in patients with mild to moderate AD, as well as prodromal (early) AD, have failed to reach efficacy endpoints in improving cognitive function in most cases to date or have been terminated due to adverse event...

Descripción completa

Detalles Bibliográficos
Autores principales: Elmaleh, David R., Farlow, Martin R., Conti, Peter S., Tompkins, Ronald G., Kundakovic, Ljiljana, Tanzi, Rudolph E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6839593/
https://www.ncbi.nlm.nih.gov/pubmed/31476157
http://dx.doi.org/10.3233/JAD-190507

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6839593/
https://www.ncbi.nlm.nih.gov/pubmed/31476157
http://dx.doi.org/10.3233/JAD-190507

Ejemplares similares